As of Dec 20, 2024, the Mannkind stock's PE ratio is 85.63. This takes into account the latest EPS of $0.08 and stock price of $6.85.
The PE ratio of Mannkind has averaged 50.11 over the last eight years. The current P/E ratio of 85.63 is 71% higher than the historical average. Looking back at the last eight years, MNKD's PE ratio peaked in the Mar 2024 quarter at 113.25, when the price was $4.53 and the EPS was $0.04. The lowest point was in the Jun 2017 quarter, when it reached 1.02 with a price of $1.41 and an EPS of $1.38.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | 2.32 | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
MNKD's current PE ratio is higher than the 10-year average.
MNKD's PE ratio stands higher than its peer stocks LLY and MRK. Mannkind's current PE ratio of 85.63 is higher than the average of its peers, which is 38.27.
Stock name | PE ratio | Market cap |
---|---|---|
HALO Halozyme Therapeutics Inc | 15.3 | $5.97B |
MRK Merck & Co Inc | 20.47 | $248.03B |
PFE Pfizer Inc | 34.68 | $149.38B |
LLY ELI LILLY & Co | 82.64 | $728.85B |
MNKD Mannkind Corp | 85.63 | $1.89B |
NKTR Nektar Therapeutics | N/A | $171.23M |
The price to earnings ratio for MNKD stock is 85.63 as of Dec 20, 2024.
The highest quarterly PE ratio in the last eight years has been 113.25 and it was in the Mar 2024 quarter.
MNKD's price to earnings ratio is currently 71% above its 8-year historical average.
MNKD's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Dec 20, 2024), Mannkind's share price is $6.85. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.08. Therefore, Mannkind's PE ratio for today is 85.63. PE RATIO(85.63) = STOCK PRICE($6.85) / TTM EPS($0.08)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.